Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine,Internal Medicine
Reference14 articles.
1. Park HJ, Jang HY, Kim SY, Lee SJ, Won HJ, Byun JH et al (2020) Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: comparison with ultrasound. J Hepatol 72:718–724. https://doi.org/10.1016/j.jhep.2019.12.001
2. Kim SY, An J, Lim Y-S, Han S, Lee J-Y, Byun JY et al (2017) MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma. JAMA Oncol 3:456–463. https://doi.org/10.1001/jamaoncol.2016.3147
3. Giorgio A (2001) Hepatitis and cirrhosis. In: Buscarini L, Campani R (eds) Abdominal ultrasound atlas, 1st edn. Idelson-Gnocchi Ltd, Napoli, pp 247–269 (ISBN-13: 9781928649182)
4. Mikami N, Ebara M, Yoshikawa M, Ohto M (1990) Relationship between ultrasound-findings of low-echoic nodule of hepatic parenchyma in liver cirrhosis and development of hepatocellular carcinoma. Jpn J Gastro-enterol 87:1010–1019
5. Rapaccini GL, Pompili M, Caturelli E, Covino M, Lippi ME, Beccaria S, Cedrone A, Riccardi L, Siena DA, Gasbarrini G (2004) Hepatocellularcarcinomas < 2 cm in diameter complicating cirrhosis: ultrasound and clinical features in 153 consecutive patients. Liver Int 24(2):124–130